Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
HRTX US
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
HRTX US
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Heron Therapeutics, Inc. /DE/
(HRTX US)
$0.29
-0.01
3.15%
(Market Open · 20:46:47 UTC)
Ask AI
Follow
Doc Search
Profile
Entity Structure
SEC Filings
Financials
Charting
Short Interest
Employees
Heron Therapeutics, Inc. /DE/
(HRTX US)
$0.29
-0.01
3.15%
(Market Open · 20:46:47 UTC)
Ask AI
Follow
Doc Search
Profile
Entity Structure
SEC Filings
Financials
Charting
Short Interest
Employees
Chronological
By Owner
Financials & Metrics
Financials
Charting
Short Interest
Employees
Chronological
By Owner
Financials & Metrics
Financials
Charting
Short Interest
Employees
Chronological SEC Filings
Chronological SEC Filings
Select Filings
Non-Ownership Filings
(688)
Expand
S-8
Registration statement (employee benefit plan)
27 Oct
8-K
Entry into a Material Definitive Agreement
29 Sep
8-K
Entry into a Material Definitive Agreement
14 Aug
10-Q
Q2
ended 30 Jun 2026
10 Aug
8-K
Results of Operations and Financial Condition
10 Aug
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
25 Jun
8-K
Submission of Matters to a Vote of Security Holders
16 Jun
8-K
Other Events
2 Jun
10-Q
Q1
ended 31 Mar 2026
11 May
8-K
Results of Operations and Financial Condition
11 May
ARS
Annual report to security holders
30 Apr
DEFA14A
Definitive additional materials
30 Apr
DEF 14A
Definitive proxy statement
30 Apr
PRE 14A
Preliminary proxy statement
20 Apr
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
6 Apr
10-K
FY 2025
ended 31 Dec 2025
26 Feb
8-K
Results of Operations and Financial Condition
26 Feb
8-K
Regulation FD Disclosure
9 Jan
10-Q
Q3
ended 30 Sept 2025
4 Nov 2025
8-K
Results of Operations and Financial Condition
4 Nov 2025
Ownership Filings
(811)
Expand
4
Statement of changes in beneficial ownership
12:57PM
4
Statement of changes in beneficial ownership
12:54PM
4
Statement of changes in beneficial ownership
12:53PM
4
Statement of changes in beneficial ownership
12:50PM
4
Statement of changes in beneficial ownership
21 Oct
4
Statement of changes in beneficial ownership
21 Oct
4
Statement of changes in beneficial ownership
21 Oct
4
Statement of changes in beneficial ownership
10 Aug
4
Statement of changes in beneficial ownership
3 Aug
4
Statement of changes in beneficial ownership
3 Aug
4
Statement of changes in beneficial ownership
3 Aug
4
Statement of changes in beneficial ownership
3 Aug
4
Statement of changes in beneficial ownership
20 Jul
4
Statement of changes in beneficial ownership
20 Jul
4
Statement of changes in beneficial ownership
20 Jul
4
Statement of changes in beneficial ownership
17 Jun
4
Statement of changes in beneficial ownership
8 Jun
SC 13G/A
HERON THERAPEUTICS, INC. /DE/
13 May
4
Statement of changes in beneficial ownership
7 May
4
Statement of changes in beneficial ownership
4 May
Select Filings
Non-Ownership Filings
(688)
Expand
S-8
Registration statement (employee benefit plan)
27 Oct
8-K
Entry into a Material Definitive Agreement
29 Sep
8-K
Entry into a Material Definitive Agreement
14 Aug
10-Q
Q2
ended 30 Jun 2026
10 Aug
8-K
Results of Operations and Financial Condition
10 Aug
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
25 Jun
8-K
Submission of Matters to a Vote of Security Holders
16 Jun
8-K
Other Events
2 Jun
10-Q
Q1
ended 31 Mar 2026
11 May
8-K
Results of Operations and Financial Condition
11 May
ARS
Annual report to security holders
30 Apr
DEFA14A
Definitive additional materials
30 Apr
DEF 14A
Definitive proxy statement
30 Apr
PRE 14A
Preliminary proxy statement
20 Apr
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
6 Apr
10-K
FY 2025
ended 31 Dec 2025
26 Feb
8-K
Results of Operations and Financial Condition
26 Feb
8-K
Regulation FD Disclosure
9 Jan
10-Q
Q3
ended 30 Sept 2025
4 Nov 2025
8-K
Results of Operations and Financial Condition
4 Nov 2025
Ownership Filings
(811)
Expand
4
Statement of changes in beneficial ownership
12:57PM
4
Statement of changes in beneficial ownership
12:54PM
4
Statement of changes in beneficial ownership
12:53PM
4
Statement of changes in beneficial ownership
12:50PM
4
Statement of changes in beneficial ownership
21 Oct
4
Statement of changes in beneficial ownership
21 Oct
4
Statement of changes in beneficial ownership
21 Oct
4
Statement of changes in beneficial ownership
10 Aug
4
Statement of changes in beneficial ownership
3 Aug
4
Statement of changes in beneficial ownership
3 Aug
4
Statement of changes in beneficial ownership
3 Aug
4
Statement of changes in beneficial ownership
3 Aug
4
Statement of changes in beneficial ownership
20 Jul
4
Statement of changes in beneficial ownership
20 Jul
4
Statement of changes in beneficial ownership
20 Jul
4
Statement of changes in beneficial ownership
17 Jun
4
Statement of changes in beneficial ownership
8 Jun
SC 13G/A
HERON THERAPEUTICS, INC. /DE/
13 May
4
Statement of changes in beneficial ownership
7 May
4
Statement of changes in beneficial ownership
4 May
Ask in Filing
Ask in Filing
